Three-dimensional co-culture of C2C12/PC12 cells improves skeletal muscle tissue formation and function

Journal of Tissue Engineering and Regenerative Medicine

Volumn 11, Issue 2, 2017, Pages 582-595

  Ostrovidov, Serge ^a   Ahadian, Samad ^a   Ramon Azcon, Javier ^a   Hosseini, Vahid ^b   Fujie, Toshinori ^c   Parthiban, S Prakash ^a   Shiku, Hitoshi ^a   Matsue, Tomokazu ^a   Kaji, Hirokazu ^a   Ramalingam, Murugan ^a,d,e   Bae, Hojae ^f   Khademhosseini, Ali ^a,g,h,i,j  

^a TOHOKU UNIVERSITY   (Japan)

^b ETH ZURICH   (Switzerland)

^c WASEDA UNIVERSITY   (Japan)

^d CHRISTIAN MEDICAL COLLEGE   (India)

^e UNIVERSITÉ DE STRASBOURG   (France)

^f Konkuk University   (South Korea)

^g Kyung Hee University   (South Korea)

^h MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

ⁱ HARVARD UNIVERSITY   (United States)

^j KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

more..

Author keywords

C2C12; hydrogel; methacrylated gelatin; muscle; myogenesis; myotubes; PC12

Indexed keywords

CELLS; COPYRIGHTS; CYTOLOGY; HISTOLOGY; HYDROGELS;

C2C12; CO-CULTURES; METHACRYLATED GELATIN; MUSCLE TISSUES; MYOBLASTS; MYOGENESIS; MYOTUBES; NEURAL CELLS; PC12 CELLS; SKELETAL MUSCLE;

MUSCLE;

ACETYLCHOLINESTERASE; ACTININ; ALPHA ACTININ; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR EPSILON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2A; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2B; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2D; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS PN; MYOGENIC FACTOR 5; MYOGENIN; SARCOMERIC ACTININ; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; GELATIN; MESSENGER RNA; MUSCLE PROTEIN;

ANIMAL CELL; ARTICLE; C2C12 MYOBLAST; CELL AGGREGATION; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL ELONGATION; CELL PROLIFERATION; CELL SHAPE; CELL SPREADING; COCULTURE; CONTROLLED STUDY; DNA SYNTHESIS; ELECTROSTIMULATION; GENE EXPRESSION; MOUSE; MUSCLE DEVELOPMENT; MUSCLE FUNCTION; MYOBLAST; MYOTUBE; NERVE CELL; NONHUMAN; PC12 NERVE CELL; PROTEIN EXPRESSION; RAT; RNA EXTRACTION; SKELETAL MUSCLE; UPREGULATION; ANIMAL; CELL LINE; CHEMISTRY; CYTOLOGY; FIBROBLAST; GENE EXPRESSION PROFILING; HYDROGEL; METABOLISM; MUSCLE CONTRACTION; PC12 CELL LINE; PHYSIOLOGY; PIG; PROCEDURES; SARCOMERE; SKELETAL MUSCLE CELL; TISSUE ENGINEERING;

ANIMALS; BIOMARKERS; CELL DIFFERENTIATION; CELL LINE; COCULTURE TECHNIQUES; FIBROBLASTS; GELATIN; GENE EXPRESSION PROFILING; HYDROGELS; MICE; MUSCLE CONTRACTION; MUSCLE DEVELOPMENT; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOBLASTS; PC12 CELLS; RATS; RNA, MESSENGER; SARCOMERES; SWINE; TISSUE ENGINEERING;

EID: 85011844296     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1956     Document Type: Article

References (80)

1. Bach AD, Beier JP, Stark GB. 2003; Expression of Trisk 51, agrin and nicotinic-acetycholine receptor-ε subunit during muscle development in a novel three-dimensional muscle-neuronal co-culture system. Cell Tissue Res 314: 263–274.
2. Bajaj P, Reddy B, Millet L et al. 2011; Patterning the differentiation of C2C12 skeletal myoblasts. Integr Biol 3: 897–909.
3. Bandi E, Jevsek M, Mars T et al. 2008; Neural agrin controls maturation of the excitation–contraction coupling mechanism in human myotubes developing in vitro. Am J Physiol Cell Physiol 294: C66–C73.
4. Bian W, Bursac N. 2012; Soluble miniagrin enhances contractile function of engineered skeletal muscle. FASEB J 26: 955–965.
5. Boonen KJM, Langelaan MLP, Polak RB et al. 2010; Effects of a combined mechanical stimulation protocol: Value for skeletal muscle tissue engineering. J Biomech 43: 1514–1521.
6. Clark P, Connolly P, Curtis AS et al. 1990; Topographical control of cell behaviour: II. Multiple grooved substrata. Development 108: 635–644.
7. Clark P, Dunn GA, Knibbs A et al. 2002; Alignment of myoblasts on ultrafine gratings inhibits fusion in vitro. Int J Biochem Cell B 34: 816–825.
8. Cohen TJ, Waddell DS, Barrientos T et al. 2007; The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming. J Biol Chem 282: 33752–33759.
9. Cooper ST, Maxwell AL, Kizana E et al. 2004; C2C12 co-culture on a fibroblast substratum enables sustained survival of contractile, highly differentiated myotubes with peripheral nuclei and adult fast myosin expression. Cell Motil Cytoskel 58: 200–211.
10. Crne-Finderle N, Pregelj P, Sketelj J. 2005; Junctional and extrajunctional acetylcholinesterase in skeletal muscle fibers. Chem Biol Interact 157–158: 23–27.
11. Dalby MJ, Riehle MO, Johnstone H et al. 2004; Investigating the limits of filopodial sensing: a brief report using SEM to image the interaction between 10 nm high nanotopography and fibroblast filopodia. Cell Biol Int 28: 229–236.
12. Das M, Rumsey JW, Bhargava N et al. 2010; A defined long-term in vitro tissue engineered model of neuromuscular junctions. Biomaterials 31: 4880–4888.
13. Das M, Rumsey JW, Bhargava N et al. 2009; Skeletal muscle tissue engineering: a maturation model promoting long-term survival of myotubes, structural development of the excitation–contraction coupling apparatus and neonatal myosin heavy chain expression. Biomaterials 30: 5392–5402.
14. Dennis R, Kosnik PE. 2000; Excitability and isometric contractile properties of mammalian skeletal muscle constructs engineered in vitro. In Vitro Cell Dev Anim 36: 327–335.
15. Dennis RG, Kosnik PE, Gilbert ME et al. 2001; Excitability and contractility of skeletal muscle engineered from primary cultures and cell lines. Am J Physiol Cell Physiol 280: C288–C295.
16. Dhawan V, Lytle IF, Dow DE et al. 2007; Neurotization improves contractile forces of tissue-engineered skeletal muscle. Tissue Eng A 13: 2813–2821.
17. Donnelly K, Khodabukus A, Philp A et al. 2010; A novel bioreactor for stimulating skeletal muscle in vitro. Tissue Eng C 16: 711–718.
18. Dugan JM, Gough JE, Eichhorn SJ. 2010; Directing the morphology and differentiation of skeletal muscle cells using oriented cellulose nanowhiskers. Biomacromolecules 11: 2498–2504.
19. Dutton EK, Uhm CS, Samuelsson SJ et al. 1995; Acetylcholine receptor aggregation at nerve–muscle contacts in mammalian cultures: induction by ventral spinal cord neurons is specific to axons. J Neurosci 15: 7401–7416.
20. Engler AJ, Griffin MA, Sen S et al. 2004; Myotubes differentiate optimally on substrates with tissue-like stiffness. J Cell Biol 166: 877–887.
21. Ferraro E, Molinari F, Berghella L. 2011; Molecular control of neuromuscular junction development. J Cachex Sarcopen Muscle 3: 1–11.
22. Fujita H, Nedachi T, Kanzaki M. 2007; Accelerated de novo sarcomere assembly by electric pulse stimulation in C2C12 myotubes. Exp Cell Res 313: 1853–1865.
23. Gajsek N, Jevsek M, Mars T et al. 2008; Synaptogenetic mechanisms controlling postsynaptic differentiation of the neuromuscular junction are nerve-dependent in human and nerve-independent in mouse C2C12 muscle cultures. Chem Biol Interact 175: 50–57.
24. Geiger PC, Bailey JP, Zhan W-Z et al. 2003; Denervation-induced changes in myosin heavy chain expression in the rat diaphragm muscle. J Appl Physiol 95: 611–619.
25. Ghaemmaghami AM, Hancock MJ, Harrington H et al. 2011; Biomimetic tissues on a chip for drug discovery. Drug Discov Today 17: 173–181.
26. Greenberg ME, Greene LA, Ziff EB. 1985; Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC12 cells. J Biol Chem 260: 14101–14110.
27. Greene LA, Tischler AS. 1976; Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A 73: 2424–2428.
28. Guo X, Gonzalez M, Stancescu M et al. 2011; Neuromuscular junction formation between human stem cell-derived motoneurons and human skeletal muscle in a defined system. Biomaterials 32: 9602–9611.
29. Guo X, Greene K, Akanda N et al. 2014; In vitro differentiation of functional human skeletal myotubes in a defined system. Biomater Sci 2: 131–138.
30. Halevy O, Novitch BG, Spicer DB et al. 1995; Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018–1021.
31. Hinds S, Bian W, Dennis RG et al. 2011; The role of extracellular matrix composition in structure and function of bioengineered skeletal muscle. Biomaterials 32: 3575–3583.
32. Hosseini V, Ahadian S, Ostrovidov S et al. 2012; Engineered contractile skeletal muscle tissue on a microgrooved methacrylated gelatin substrate. Tissue Eng A 18: 2453–2465.
33. Huang NF, Patel S, Thakar RG et al. 2006; Myotube assembly on nanofibrous and micropatterned polymers. Nano Lett 6: 537–542.
34. Huang S, Wang F, Hong G et al. 2002; Protective effects of ciliary neurotrophic factor on denervated skeletal muscle. J Huazhong U Sci Technol Med 22: 148–151.
35. Hughes BW, Kusner LL, Kaminski HJ. 2006; Molecular architecture of the neuromuscular junction. Muscle Nerve 33: 445–461.
36. Hutmacher D, Duda G, Guldberg R. 2012; Endogenous musculoskeletal tissue regeneration. Cell Tissue Res 347: 485–488.
37. Ito A, Yamamoto Y, Sato M et al. 2014; Induction of functional tissue-engineered skeletal muscle constructs by defined electrical stimulation. Sci Rep 4. DOI: 10.1038/srep04781
38. Jevsek M, Mars T, Mis K et al. 2004; Origin of acetylcholinesterase in the neuromuscular junction formed in the in vitro innervated human muscle. Eur J Neurosci 20: 2865–2871.
39. Jiang JXS, Choi RCY, Siow NL et al. 2003; Muscle induces neuronal expression of acetylcholinesterase in neuron–muscle co-culture. J Biol Chem 278: 45435–45444.
40. Koffler J, Kaufman-Francis K, Shandalov Y et al. 2012; Improved vascular organization enhances functional integration of engineered skeletal muscle grafts. Proc Natl Acad Sci U S A 108: 14789–14794.
41. Lam MT, Sim S, Zhu X et al. 2006; The effect of continuous wavy micropatterns on silicone substrates on the alignment of skeletal muscle myoblasts and myotubes. Biomaterials 27: 4340–4347.
42. Langelaan MLP, Boonen KJM, Rosaria-Chak KY et al. 2011; Advanced maturation by electrical stimulation: Differences in response between C2C12 and primary muscle progenitor cells. J Tissue Eng Regen Med 5: 529–539.
43. Larkin L, van der Meulen J, Dennis R et al. 2006; Functional evaluation of nerve–skeletal muscle constructs engineered in vitro. In Vitro Cell Dev B 42: 75–82.
44. Lassar AB, Skapek SX, Novitch B. 1994; Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr Opin Cell Biol 6: 788–794.
45. Liao IC, Liu J, Bursac N et al. 2008; Effect of electromechanical stimulation on the maturation of myotubes on aligned electrospun fibers. Cell Mol Bioeng 1: 133–145.
46. McGeachie AB, Koishi K, Andrews ZB et al. 2005; Analysis of mRNAs that are enriched in the post-synaptic domain of the neuromuscular junction. Mol Cell Neurosci 30: 173–185.
47. Marques MJ, Santo Neto H. 1997; Ciliary neurotrophic factor stimulates in vivo myotube formation in mice. Neurosci Lett 234: 43–46.
48. Massoulie J, Millard CB. 2009; Cholinesterases and the basal lamina at vertebrate neuromuscular junctions. Curr Opin Pharmacol 9: 316–325.
49. Mathew SJ, Hansen JM, Merrell AJ et al. 2011; Connective tissue fibroblasts and Tcf4 regulate myogenesis. Development 138: 371–384.
50. Midrio M. 2006; The denervated muscle: facts and hypotheses. A historical review. Eur J Appl Physiol 98: 1–21.
51. Nagamine K, Otani S, Takeda M et al. Hydrogel-supported skeletal muscle cell-based bioassay system. In International Symposium on Micro-nano Mechatronics and Human Science (MHS), 2011; 180–185.
52. Nedachi T, Fujita H, Kanzaki M. 2008; Contractile C2C12 myotube model for studying exercise-inducible responses in skeletal muscle. Am J Physiol Endocrinol Metab 295: E1191–E1204.
53. Ostrovidov S, Hosseini V, Ahadian S et al. 2014a; Skeletal muscle tissue engineering: methods to form skeletal myotubes and their applications. Tissue Eng B Rev. DOI: 10.1089/ten.teb.2013.0534
54. Ostrovidov S, Jiang J, Sakai Y et al. 2004; Membrane-based PDMS microbioreactor for perfused 3D primary rat hepatocyte cultures. Biomed Microdevices 6: 279–287.
55. Ostrovidov S, Sakai Y, Fujii T. 2011; Integration of a pump and an electrical sensor into a membrane-based pdms microbioreactor for cell culture and drug testing. Biomed Microdevices 13: 847–864.
56. Ostrovidov S, Shi X, Zhang L et al. 2014b; Myotube formation on gelatin nanofibers – multi-walled carbon nanotubes hybrid scaffolds. Biomaterials. DOI: 10.1016/j.biomaterials.2014.1004.1021
57. Park H, Bhalla R, Saigal R et al. 2008; Effects of electrical stimulation in C2C12 muscle constructs. J Tissue Eng Regen Med 2: 279–287.
58. Pennisi CP, Olesen CG, de Zee M et al. 2011; Uniaxial cyclic strain drives assembly and differentiation of skeletal myocytes. Tissue Eng A 17: 2543–2550.
59. Periasamy M, Wieczorek DF, Nadal-Ginard B. 1984; Characterization of a developmentally regulated perinatal myosin heavy-chain gene expressed in skeletal muscle. J Biol Chem 259: 13573–13578.
60. Portiér G, Benders A, Oosterhof A et al. 1999; Differentiation markers of mouse C2C12 and rat L6 myogenic cell lines and the effect of the differentiation medium. In Vitro Cell Dev Anim 35: 219–227.
61. Pregelj P, Trinkaus M, Zupan D et al. 2007; The role of muscle activation pattern and calcineurin in acetylcholinesterase regulation in rat skeletal muscles. J Neurosci 27: 1106–1113.
62. Ramon J, Ahadian S, Obregon R et al. 2012; Gelatin methacrylate as a promising hydrogel for 3D microscale organization and proliferation of dielectrophoretically patterned cells. Lab Chip 12: 2959–2969.
63. Rende M, Brizi E, Conner J et al. 2000; Nerve growth factor (NGF) influences differentiation and proliferation of myogenic cells in vitro via TrKA. Int J Dev Neurosci 18: 869–885.
64. Rhim C, Lowell DA, Reedy MC et al. 2007; Morphology and ultrastructure of differentiating three-dimensional mammalian skeletal muscle in a collagen gel. Muscle Nerve 36: 71–80.
65. Rhodes SJ, Konieczny SF. 1989; Identification of MRF4: a new member of the muscle regulatory factor gene family. Genes Dev 3: 2050–2061.
66. Rimer M, Mathiesen I, Lomo T et al. 1997; γ-AChR/ɛ-AChR switch at agrin-induced postsynaptic-like apparatus in skeletal muscle. Mol Cell Neurosci 9: 254–263.
67. Rubin LL, Schuetze SM, Weill CL et al. 1980; Regulation of acetylcholinesterase appearance at neuromuscular junctions in vitro. Nature 283: 264–267.
68. Salmons S, Ashley Z, Sutherland H et al. 2005; Functional electrical stimulation of denervated muscles: basic issues. Artif Organs 29: 199–202.
69. Sasagawa T, Shimizu T, Sekiya S et al. 2010; Design of prevascularized three-dimensional cell-dense tissues using a cell sheet stacking manipulation technology. Biomaterials 31: 1646–1654.
70. Schmittgen TD, Livak KJ. 2008; Analyzing real-time PCR data by the comparative Ct method. Nat Protoc 3: 1101–1108.
71. Seidl K, Erck C, Buchberger A. 1998; Evidence for the participation of nerve growth factor and its low-affinity receptor (p75NTR) in the regulation of the myogenic program. J Cell Physiol 176: 10–21.
72. Sirivisoot S, Pareta R, Harrison BS. 2014; Protocol and cell responses in three-dimensional conductive collagen gel scaffolds with conductive polymer nanofibres for tissue regeneration. Interface Focus 4. DOI: 10.1098/rsfs.2013.0050
73. Tsim KWK, Choi RCY, Xie HQ et al. 2008; Transcriptional control of different subunits of ache in muscles: signals triggered by the motor nerve-derived factors. Chem Biol Interact 175: 58–63.
74. Uezato T, Sato E, Miura N. 2012; Screening of natural medicines that efficiently activate neurite outgrowth in PC12 cells in C2C12-cultured medium. Biomed Res 33: 25–33.
75. van der Schaft DWJ, van Spreeuwel ACC, van Assen HC et al. 2011; Mechanoregulation of vascularization in aligned tissue-engineered muscle: a role for vascular endothelial growth factor. Tissue Eng Pt A 17: 2857–2865.
76. Vandenburgh H. 2010; High-content drug screening with engineered musculoskeletal tissues. Tissue Eng B Rev 16: 55–64.
77. Wright WE, Sassoon DA, Lin VK. 1989; Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 56: 607–617.
78. Xie HQ, Choi RCY, Leung KW et al. 2007; Regulation of a transcript encoding the proline-rich membrane anchor of globular muscle acetylcholinesterase: the suppressive roles of myogenesis and innervating nerves. J Biol Chem 282: 11765–11775.
79. Yamamoto Y, Ito A, Fujita H et al. 2010; Functional evaluation of artificial skeletal muscle tissue constructs fabricated by a magnetic force-based tissue engineering technique. Tissue Eng A 17: 107–114.
80. Zorlutuna P, Jeong JH, Kong H et al. 2011; Stereolithography-based hydrogel microenvironments to examine cellular interactions. Adv Funct Mater 21: 3642–3651.